Study guide

1.2 Prenatal History, Obstetric Notation & Gestational Dating

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

1.2 Prenatal History, Obstetric Notation & Gestational Dating

Key Takeaways Explain This Topic AI

First-trimester crown-rump length is the most accurate dating measurement, with a margin of error of plus or minus 5 to 7 days.

ACOG redating thresholds widen with gestational age: more than 5 days at 8 6/7 weeks or earlier, more than 7 days from 9 0/7 to 15 6/7 weeks, more than 10 days from 16 0/7 to 21 6/7 weeks, more than 14 days from 22 0/7 to 27 6/7 weeks, and more than 21 days at 28 0/7 weeks or later.

An estimated date of delivery derived from in vitro fertilization embryo transfer is never changed by subsequent ultrasound biometry.

In TPAL notation a twin birth at 35 weeks counts as one preterm delivery but two living children, so a patient delivering 38-week twins in her first pregnancy is G1 P1, TPAL 1-0-0-2.

Intimate partner violence screening must be conducted privately at the initial visit, once each trimester, and postpartum, with the patient unaccompanied.

Last updated: September 2026

The initial prenatal evaluation is the cornerstone of antepartum midwifery care. It establishes baseline maternal physiological parameters, identifies preexisting medical or genetic risks, accurately determines the estimated date of delivery (EDD), and initiates a partnership grounded in shared decision-making. For the AMCB examination, the certified nurse-midwife (CNM) must demonstrate mastery of obstetric terminology, accurate gestational dating rules, baseline laboratory interpretation, and counseling regarding genetic screening modalities.

Comprehensive Health History & Risk Stratification

The first prenatal encounter requires a systematic health history encompassing medical, surgical, gynecologic, genetic, psychiatric, and social domains.

Universal Screenings in Early Pregnancy

Intimate Partner Violence (IPV): ACOG and ACNM mandate universal, private, face-to-face screening at the initial visit, repeated once per trimester and postpartum. Screening must occur when the patient is unaccompanied. Validated screening tools (e.g., HARK, HITS) should be used, followed by trauma-informed safety planning and resource provision when disclosures occur.

Substance Use: Universal screening using validated verbal instruments (such as the 4Ps Plus, CRAFFT for adolescents, or 5Ps) under the Screening, Brief Intervention, and Referral to Treatment (SBIRT) framework. Urine drug toxicology testing should never be ordered without explicit, informed patient consent.

Depression & Anxiety: Baseline screening using validated questionnaires (Edinburgh Postnatal Depression Scale [EPDS] or Patient Health Questionnaire-9 [PHQ-9]) to identify preexisting or emerging perinatal mood disorders.

Obstetric History Documentation: The GP (TPAL) System

Precise obstetric notation provides immediate insight into a patient's reproductive history and recurrence risks for complications such as preterm birth or recurrent pregnancy loss.

Definitions

Gravida (G): Total number of pregnancies, regardless of duration, location (intrauterine vs. ectopic), or clinical outcome. The current pregnancy is included in the count.

Para (P): Number of completed pregnancies that have reached the threshold of viability (traditionally defined as ≥20 0/7 weeks of gestation or a fetal birth weight of ≥500 grams ), regardless of whether the infant was born alive or stillborn.

The TPAL Four-Digit Parity Breakdown

To communicate obstetric history with clinical precision, the TPAL system is standard:

T (Term): Deliveries occurring at ≥37 0/7 weeks of gestation (early term, full term, late term, or postterm).

P (Preterm): Deliveries occurring between 20 0/7 and 36 6/7 weeks of gestation.

A (Abortion): Pregnancies ending prior to 20 0/7 weeks of gestation (includes spontaneous pregnancy losses, induced abortions, ectopic pregnancies, and hydatidiform moles).

L (Living): Number of biological children currently alive.

Clinical History Scenario Gravida / Para TPAL Notation Key Midwifery Takeaway

Currently pregnant; previously delivered twins at 34 weeks (both living), had a miscarriage at 8 weeks, and delivered a singleton at 39 weeks (living) G4 P2 G4 P 1-1-1-3 Multifetal pregnancies count as one pregnancy event and one delivery event for G and P, but individual infants are counted under L (Living) .

Currently pregnant; history of an ectopic pregnancy at 6 weeks and an elective termination at 10 weeks; no births G3 P0 G3 P 0-0-2-0 Ectopic pregnancies and early terminations fall strictly into the A (Abortion) category.

First-time pregnancy, no prior losses G1 P0 G1 P 0-0-0-0 Primigravida / nulliparous.

Important

On the AMCB exam, pay close attention to twins and higher-order multiples. A twin delivery at 35 weeks counts as one preterm delivery (P = 1) , but yields two living children (L = 2) . A woman who delivers twins at 38 weeks is G1 P1 (TPAL: 1-0-0-2).

Estimated Date of Delivery (EDD) Determination

Accurate gestational age assignment directs all subsequent clinical care, including the timing of aneuploidy screening, anatomy ultrasound, surveillance for fetal growth disorders, and postterm management.

Menstrual Dating: Naegele's Rule

Naegele's rule calculates the EDD based on a standard 28-day menstrual cycle where ovulation occurs precisely on cycle day 14: EDD = First day of Last Normal Menstrual Period (LMP) + 7 days − 3 months + 1 year \text{EDD} = \text{First day of Last Normal Menstrual Period (LMP)} + 7 \text{ days} - 3 \text{ months} + 1 \text{ year} EDD = First day of Last Normal Menstrual Period (LMP) + 7 days − 3 months + 1 year

Example: An LMP starting on May 12, 2026 yields an EDD of February 19, 2027 (May 12 + 7 days = May 19; May - 3 months = February).

Adjustments for Non-28-Day Cycles: If a patient has regular cycles of a different length, calculate: Adjustment = Cycle Length − 28 days \text{Adjustment} = \text{Cycle Length} - 28 \text{ days} Adjustment = Cycle Length − 28 days Add or subtract these days accordingly. For a regular 35-day cycle, add 7 additional days to the calculated EDD.

Ultrasound Dating Discrepancy Criteria

Menstrual dating assumes regular ovulatory cycles and precise patient recall. When an early ultrasound measurement disagrees with the LMP dating, the midwife must apply the ACOG / SMFM / AIUM consensus criteria to decide whether to retain the LMP date or redate to the ultrasound.

Crown-rump length (CRL) measured in the first trimester is the most accurate fetal biometric parameter, with a margin of error of ±5 to 7 days .

Gestational Age Range Biometric Measurement Method Discrepancy Margin Triggering EDD Change Clinical Action When Discrepancy Exceeds Margin

  • ≤8 6/7 weeks Crown-Rump Length (CRL) >5 days Redate EDD to ultrasound date
  • 9 0/7 to 13 6/7 weeks Crown-Rump Length (CRL) >7 days Redate EDD to ultrasound date

14 0/7 to 15 6/7 weeks Biparietal diameter, head circ., femur length, abd. circ. >7 days Redate EDD to ultrasound date

  • 16 0/7 to 21 6/7 weeks Full fetal biometry (BPD, HC, AC, FL) >10 days Redate EDD to ultrasound date
  • 22 0/7 to 27 6/7 weeks Full fetal biometry (BPD, HC, AC, FL) >14 days Redate EDD to ultrasound date
  • ≥28 0/7 weeks Full fetal biometry (BPD, HC, AC, FL) >21 days Redate EDD to ultrasound date

Special Case (Assisted Reproductive Technology): For pregnancies conceived via in vitro fertilization (IVF), the EDD is derived directly from the date of embryo transfer (e.g., embryo transfer date + 266 days - embryo age in days). The IVF dating is never altered by subsequent ultrasound biometry.